Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2025-12-31 @ 7:43 PM
Study NCT ID:
NCT01647828
Status:
COMPLETED
Last Update Posted:
2023-02-15
First Post:
2012-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
Sponsor:
OncoMed Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
None
Primary Completion Date:
2016-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-11
First Submit QC Date:
None
Study First Post Date:
2012-07-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-12
Results First Submit QC Date:
None
Results First Post Date:
2023-02-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-19
Last Update Post Date:
2023-02-15
Last Update Post Date Type:
ACTUAL